EP Patent

EP1874282B1 — Methods and compositions for treatment of cns disorders

Assigned to Adamas Pharmaceuticals Inc · Expires 2010-09-15 · 16y expired

What this patent protects

The invention relates to methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.

USPTO Abstract

The invention relates to methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.

Drugs covered by this patent

Patent Metadata

Patent number
EP1874282B1
Jurisdiction
EP
Classification
Expires
2010-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Adamas Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.